Metabolic status and vascular endothelial structure in obese hypertensive patients treated with non-pharmacological therapies: A systematic review and meta-analysis

Abstract

Objective This meta-analysis aimed to evaluate the efficacy of non-drug treatment on metabolism and vascular endothelium in obese hypertension. Methods Relevant publications were searched in the PubMed, Embase, and Cochrane Library databases for clinical studies on the effects of non-pharmacological treatments in obese hypertensive patients published from inception to April 2022. After searching and screening the literature, information was extracted, and the quality of the literature was evaluated by the investigators. Data processing was performed using Rev Man 5.3 statistical analysis software, while the TSA 0.9 software was used for sequential analysis of blood pressure and endothelial-related indicators. Results A total of 8 literature articles with 480 patients were included. The analysis showed that non-pharmacological treatment effectively reduced systolic blood pressure, diastolic blood pressure, heart rate, body weight, body mass index, glucose levels, soluble intercellular adhesion molecule 1, triglycerides, triglycerides, Low-density lipoprotein. For tumor necrosis factor α, soluble vascular cell adhesion molecule 1, high-density lipoprotein, C-reactive protein, high-sensitive C-reactive protein, and total antioxidant status by dietary supplements mainly. In contrast, no significant treatment effect was observed for Endothelin-1. Sequential analysis of the trial showed definitive evidence for improvement in blood pressure and inflammation. Conclusion Non-pharmacological treatment of obese hypertensive patients may reduce blood pressure, body weight, and blood glucose, control inflammatory factor release and improve vascular endothelium to some extent.

Oxidative Stress Responses in Obese Individuals Undergoing Bariatric Surgery: Impact on Carcinogenesis

“…Despite lifestyle intervention efficacy, bariatric surgery has been described as the best therapeutic option for sustained weight loss, especially in advanced cases, i.e., morbid obesity and related comorbidities [ 4 ]. It has been demonstrated that weight loss in obese individuals reduces low-density lipoprotein cholesterol (LDL-C) levels, triglycerides, soluble intercellular adhesion molecule 1, fasting glucose concentrations, and systolic and diastolic blood pressure [ 5 ]. In fact, multiple follow-up studies have assumed successful control of diabetes mellitus and hypertension in association with weight loss from bariatric surgery, as well as a significant reduction in mortality [ 6 , 7 , 8 , 9 ].…”